BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 34698689)

  • 1. Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network.
    Romeo C; Le Saux O; Jacobs M; Joly F; Ferron G; Favier L; Fumet JD; Isambert N; Colombo PE; Sabatier R; Bastide L; Charreton A; Devouassoux-Shisheboran M; Gertych W; Dubot C; Bello Roufai D; Bataillon G; Berton D; Kalbacher E; Pautier P; Pomel C; Cornou C; Treilleux I; Lardy-Cleaud A; Ray-Coquard I
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids.
    Dahl MJ; Lofgren KA; Haugen C; Harmon GE; Hughes SP; Cowden Dahl KD
    Front Oncol; 2024; 14():1368592. PubMed ID: 38544842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy in uterine carcinosarcoma: Comparison of a doublet and a triplet chemotherapeutic regimen.
    Maheshwari U; Rajappa SK; Talwar V; Goel V; Dash PK; Sharma M; Goyal P; Jain P; B Koyyala VP; Doval DC
    Indian J Cancer; 2021; 58(2):179-184. PubMed ID: 33753600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
    Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I
    Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.
    Homesley HD; Filiaci V; Markman M; Bitterman P; Eaton L; Kilgore LC; Monk BJ; Ueland FR;
    J Clin Oncol; 2007 Feb; 25(5):526-31. PubMed ID: 17290061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
    Einstein MH; Klobocista M; Hou JY; Lee S; Mutyala S; Mehta K; Reimers LL; Kuo DY; Huang GS; Goldberg GL
    Gynecol Oncol; 2012 Jan; 124(1):26-30. PubMed ID: 22055846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.
    Makker V; Abu-Rustum NR; Alektiar KM; Aghajanian CA; Zhou Q; Iasonos A; Hensley ML
    Gynecol Oncol; 2008 Nov; 111(2):249-54. PubMed ID: 18755503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma.
    Su MH; Wu HH; Huang HY; Lee NR; Chang WH; Lin SC; Chen YJ; Wang PH
    J Chin Med Assoc; 2022 Feb; 85(2):204-211. PubMed ID: 34698689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
    Galaal K; van der Heijden E; Godfrey K; Naik R; Kucukmetin A; Bryant A; Das N; Lopes AD
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006812. PubMed ID: 23450572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
    Galaal K; Godfrey K; Naik R; Kucukmetin A; Bryant A
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006812. PubMed ID: 21249682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future perspectives in advanced bladder cancer: is there a new standard?
    von der Maase H
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Recommended Treatment of Uterine Carcinosarcoma.
    Menczer J
    Curr Treat Options Oncol; 2015 Nov; 16(11):53. PubMed ID: 26374341
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.